Wealth Growth Daily

Health

BlackRock to call staff back to office at least four days a week – memo

BY Reuters  • May 16, 2023May 16, 2023
(Reuters) – BlackRock Inc, the world’s largest asset manager, has asked its staff to return to office at least four days a week, according to an internal memo seen by Reuters. “We wi[...]
Read more
Business Health US

AstraZeneca to leave leading U.S. drug lobby group

BY Reuters  • May 16, 2023May 16, 2023
By Maggie Fick LONDON (Reuters) -AstraZeneca has decided to leave the main U.S. drug lobby group, the Pharmaceutical Research and Manufacturers of America (PhRMA), and pursue other ways of engaging in[...]
Read more
Business Economy Europe Health UK Updated

Abbott Labs is sued over PediaSure height claims

BY Reuters  • May 15, 2023May 15, 2023
By Jonathan Stempel NEW YORK (Reuters) -A New York City woman sued Abbott Laboratories on Monday, accusing the healthcare company of misleading consumers into believing its PediaSure nutrition drinks[...]
Read more
Business Health Updated

Natera wins $19 million US verdict from ArcherDX in cancer-detection patent case

BY Reuters  • May 15, 2023May 15, 2023
By Blake Brittain (Reuters) – Genetic testing company Natera Inc convinced a Delaware federal jury on Monday to award it $19.3 million in damages from Invitae Corp’s ArcherDX for infringin[...]
Read more
Business Health Science US

US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute

BY Reuters  • May 15, 2023May 15, 2023
By Blake Brittain WASHINGTON (Reuters) – The U.S. Supreme Court on Monday declined to hear Teva Pharmaceuticals USA Inc’s challenge to a $235 million award to GlaxoSmithKline LLC in a pate[...]
Read more
Business Economy Europe Health Middle East Politics UK US

Sarepta surges after FDA panel backs Duchenne gene therapy

BY Reuters  • May 15, 2023May 15, 2023
By Aditya Samal (Reuters) -Shares of Sarepta Therapeutics jumped 25% on Monday as a backing by the U.S. health regulator’s advisers increased the certainty of an accelerated approval for the com[...]
Read more
Business Health

G7 plans new vaccine effort for developing nations, Yomiuri reports

BY Reuters  • May 13, 2023May 13, 2023
TOKYO (Reuters) -The Group of Seven (G7) rich nations is set to agree on establishing a new programme to distribute vaccines to developing countries at next week’s summit of leaders, Japan[...]
Read more
Asia Business Canada Economy Europe Health UK Updated US

Shareholders of Evergrande’s EV unit agree on restructuring deal

BY Reuters  • May 13, 2023May 13, 2023
By Xie Yu HONG KONG (Reuters) – Shareholders of China Evergrande New Energy Vehicle Group accepted a proposal to dispose of two subsidiaries in a restructuring, according to a filing with the Ho[...]
Read more
Asia Business Economy Health

FDA issues marketing denial for 6,500 flavored e-cigarettes

BY Reuters  • May 12, 2023May 12, 2023
(Reuters) -The U.S. Food and Drug Administration (FDA) on Friday issued marketing denial orders to 10 companies which collectively manufacture and market about 6,500 flavored e-liquid and e-cigarette[...]
Read more
Business Health Updated
« Previous 1 … 12 13 14 15 16 … 52 Next »
Wealth Growth Daily
PRIVACY POLICY

Copyright © 2026 Wealth Growth Daily. All Rights Reserved.

HIGH RISK WARNING

Trading foreign exchange, stocks, options, or futures on margin carries a high level of risk, and may not be suitable for all investors. Before deciding to trade, you should carefully consider your objectives, financial situation, needs and level of experience. Wealth Growth Daily provides general advice that does not take into account your objectives, financial situation or needs. The content of this website must not be construed as personal advice. The possibility exists that you could sustain a loss in excess of your deposited funds and therefore, you should not speculate with capital that you cannot afford to lose. You should be aware of all the risks associated with trading on margin. You should seek advice from an independent financial advisor. Past performance is not necessarily indicative of future success.

101 Marketside Ave. Suite 404 PMB 318 Ponte Vedra, FL 32081 | (321) 325-1551